As of 2025-09-14, the Intrinsic Value of EKF Diagnostics Holdings PLC (EKF.L) is 22.60 GBP. This EKF.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 29.30 GBP, the upside of EKF Diagnostics Holdings PLC is -22.90%.
The range of the Intrinsic Value is 15.98 - 45.78 GBP
Based on its market price of 29.30 GBP and our intrinsic valuation, EKF Diagnostics Holdings PLC (EKF.L) is overvalued by 22.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 15.98 - 45.78 | 22.60 | -22.9% |
| DCF (Growth 10y) | 17.19 - 46.53 | 23.78 | -18.9% |
| DCF (EBITDA 5y) | 21.96 - 30.91 | 24.61 | -16.0% |
| DCF (EBITDA 10y) | 21.60 - 32.19 | 25.04 | -14.5% |
| Fair Value | 32.32 - 32.32 | 32.32 | 10.31% |
| P/E | 25.95 - 47.52 | 36.85 | 25.8% |
| EV/EBITDA | 26.21 - 36.04 | 30.52 | 4.2% |
| EPV | 20.85 - 29.44 | 25.15 | -14.2% |
| DDM - Stable | 12.42 - 54.97 | 33.69 | 15.0% |
| DDM - Multi | 11.67 - 41.70 | 18.42 | -37.1% |
| Market Cap (mil) | 141.46 |
| Beta | -0.13 |
| Outstanding shares (mil) | 4.83 |
| Enterprise Value (mil) | 128.48 |
| Market risk premium | 5.98% |
| Cost of Equity | 8.20% |
| Cost of Debt | 4.29% |
| WACC | 8.07% |